Moleculin Biotech, Inc. (MBRX)
2.23
-0.06
(-2.62%)
USD |
NASDAQ |
Apr 01, 16:00
2.19
-0.04
(-1.79%)
Pre-Market: 09:23
Moleculin Biotech EPS Diluted (Quarterly) : 4.829 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.55M |
| Total Expenses (Quarterly) | -15.55M |
| Enterprise Value | -3.903M |
| Earnings Yield | -1.16K% |
| Normalized Earnings Yield | -1507.13 |